MOUNJARO FDA approval date

The FDA approved MOUNJARO on 13 May 2022.

FDA approval date
13 May 2022

Drug identity has not yet been verified against registry records

Also recorded as TIRZEPATIDE

Included trials

No linked trials for this drug yet. Browse all trials

PDUFA dates and FDA decisions

Date as reportedDrug / companyEventConditionEvidence
2022-05-13DayMOUNJAROFDA original application approvalFDA approval decisionNot specifiedOpen original source
Read source excerpt

{"application_number": "NDA215866", "applicant_as_listed_by_fda": "ELI LILLY AND CO", "brand_names": ["MOUNJARO", "MOUNJARO (AUTOINJECTOR)", "MOUNJARO KWIKPEN"], "active_ingredients": ["TIRZEPATIDE"], "submission_type": "ORIG", "submission_number": "1", "submission_status": "AP", "submission_status_date": "20220513", "matched_on": "drug record created from this FDA brand name"}

First seen: 06 Oct 2026 · Evidence last checked: 06 Oct 2026